Moderna and Pfizer-BioNTech Vaccines Are Very Effective, Report Says

Consistent with clinical trial data, a two-dose regimen prevented 90 percent of infections by two weeks after the second shot. One dose prevented 80 percent of infections by two weeks after vaccination.